Serum TIMP-1, TIMP-2, and MMP-1 levels in patients with diffuese cutaneous systemic sclerosis (dcSSc), limited cutaneous SSc (lcSSc), Raynaud's phenomenon (RP), and in normal controls
| dcSSc | lcSSc | RP | Normal | |
| TIMP-1 (ng/ml) | ||||
| Median | 403.5 | 353.8 | 305.3 | 275.0 |
| (Interquartile range, 25th–75th) | (314.0–517.1) | (312.4–469.2) | (259.4–396.4) | (229.5–348.0) |
| Number | 83 | 87 | 80 | 98 |
| TIMP-2 (ng/ml) | ||||
| Median | 187.0 | 177.0 | 141.5 | 165.5 |
| (Interquartile range, 25th–75th) | (145.0–208.0) | (138.0–193.0) | (113.5–178.5) | (141.5–190.5) |
| Number | 83 | 87 | 80 | 92 |
| MMP-11-150 (ng/ml) | ||||
| Median | 3.530 | 3.910 | 2.390 | 2.380 |
| (Interquartile range, 25th–75th) | (1.455–7.275) | (1.505–7.060) | (1.000–4.010) | (1.640–3.780) |
| Number | 82 | 87 | 77 | 97 |
↵1-150 MMP-1 assay results shown were analysed after assigning a minimum assay result of 1 ng/ml.